IP Library Granted Patent US 7,565,205
Granted Patent B2
US 7,565,205 · App. 11/111,439 · Granted Jul 21, 2009

Treating a tumor or the like with electric fields at different orientations

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,565,205
App. No.
11/111,439
Granted
Jul 21, 2009
Kind
B2
Abstract

Cells that are in the late anaphase or telophase stages of cell division are vulnerable to damage by AC electric fields that have specific frequency and field strength characteristics. The selective destruction of rapidly dividing cells can therefore be accomplished by imposing an AC electric field in a target region for extended periods of time. Some of the cells that divide while the field is applied will be damaged, but the cells that do not divide will not be harmed. This selectively damages rapidly dividing cells like tumor cells, but does not harm normal cells that are not dividing. Since the vulnerability of the dividing cells is strongly related to the alignment between the long axis of the dividing cells and the lines of force of the electric field, improved results are obtained when the field is sequentially imposed in different directions.

Claims (73)

1. A method of selectively destroying or inhibiting the growth of rapidly dividing cells located within a target region of a patient, comprising the steps of:

imposing an AC electric field in the target region of the patient, wherein the electric field has a first orientation during a first interval of time and a second orientation during a second interval of time, wherein at least a portion of the first interval of time and the second interval of time are mutually exclusive, wherein the electric field has frequency characteristics that correspond to a vulnerability of the rapidly dividing cells, wherein the electric field is strong enough to damage, during the late anaphase or telophase stages of cell division, a significant portion of the rapidly dividing cells whose long axis is generally aligned with the lines of force of the electric field, and wherein the electric field leaves non-dividing cells located within the target region substantially unchanged; and

repeating the imposing step until a therapeutically significant portion of the rapidly dividing cells die.

2. The method of claim 1 , wherein the electric field is imposed in the target region via insulated electrodes.

3. The method of claim 1 , wherein the frequency of the electric field is between about 50 kHz and about 500 kHz.

4. The method of claim 3 , wherein the strength of the electric field in at least a portion of the target region is between about 0.1 V/cm and about 10 V/cm.

5. The method of claim 1 , wherein the frequency of the electric field is between about 100 kHz and about 300 kHz.

6. The method of claim 5 , wherein the strength of the electric field in at least a portion of the target region is between about 1 V/cm and about 5 V/cm.

7. The method of claim 1 , wherein at least two different frequencies are imposed in the target region during the imposing step.

8. The method of claim 1 , wherein the first orientation is generally perpendicular to the second orientation.

9. The method of claim 1 , wherein the first orientation is at least 30° away from the second orientation.

10. The method of claim 1 , wherein, in the imposing step, the electric field has a third orientation during a third interval of time, and wherein at least a portion of the first interval of time, the second interval of time, and the third interval of time are mutually exclusive.

11. The method of claim 1 , wherein, in the imposing step, the orientation of the electric field is gradually and sequentially shifted through a large number of orientations to generate a field vector that rotates with respect to the target region.

12. The method of claim 11 , wherein the rotating field vector is obtained by simultaneously applying non-identical AC voltages to different sets of electrodes.

13. A method of selectively destroying or inhibiting the growth of rapidly dividing cells located within a target region of a patient, comprising the steps of:

imposing an AC electric field in the target region of the patient, wherein the electric field has a first orientation during a first interval of time and a second orientation during a second interval of time, wherein at least a portion of the first interval of time and the second interval of time are mutually exclusive, wherein the electric field has frequency and field strength characteristics that cause the electric field to selectively damage cells that are undergoing cell division, and wherein the electric field leaves cells that are not undergoing cell division substantially unharmed; and

repeating the imposing step until a therapeutically significant portion of the rapidly dividing cells die.

14. The method of claim 13 , wherein the electric field is imposed in the target region via insulated electrodes.

15. The method of claim 13 , wherein the frequency of the electric field is between about 50 kHz and about 500 kHz.

16. The method of claim 15 , wherein the strength of the electric field in at least a portion of the target region is between about 0.1 V/cm and about 10 V/cm.

17. The method of claim 13 , wherein the frequency of the electric field is between about 100 kHz and about 300 kHz.

18. The method of claim 17 , wherein the strength of the electric field in at least a portion of the target region is between about 1 V/cm and about 5 V/cm.

19. The method of claim 13 , wherein at least two different frequencies are imposed in the target region during the imposing step.

20. The method of claim 13 , wherein the first orientation is generally perpendicular to the second orientation.

21. The method of claim 13 , wherein the first orientation is at least 30° away from the second orientation.

22. The method of claim 13 , wherein, in the imposing step, the electric field has a third orientation during a third interval of time, and wherein at least a port ion of the first interval of time, the second interval of time, and the third interval of time are mutually exclusive.

23. The method of claim 13 , wherein, in the imposing step, the orientation of the electric field is gradually and sequentially shifted through a large number of orientations to generate a field vector that rotates with respect to the target region.

24. The method of claim 23 , wherein the rotating field vector is obtained by simultaneously applying non-identical AC voltages to different sets of electrodes.

25. A method of selectively destroying or inhibiting the growth of rapidly dividing cells located within a target region of a patient, comprising the steps of:

sequentially subjecting a target region to AC electric fields oriented in different directions, wherein the electric fields have frequency and field strength characteristics that cause the electric field to selectively damage cells that are undergoing cell division, and wherein the electric fields leave cells that are not undergoing cell division substantially unharmed; and

repeating the subjecting step until a therapeutically significant portion of the rapidly dividing cells die.

26. The method of claim 25 , wherein the target region is subjected to the electric fields via insulated electrodes.

27. The method of claim 25 , wherein the frequency of the electric fields is between about 50 kHz and about 500 kHz.

28. The method of claim 27 , wherein the strength of the electric fields in at least a portion of the target region is between about 0.1 V/cm and about 10 V/cm.

29. The method of claim 25 , wherein the frequency of the electric fields is between about 100 kHz and about 300 kHz.

30. The method of claim 29 , wherein the strength of the electric fields in at least a portion of the target region is between about 1 V/cm and about 5 V/cm.

31. The method of claim 25 , wherein, in the imposing step, the orientation of the electric fields is gradually and sequentially shifted through a large number of orientations to generate a field vector that rotates with respect to the target region.

32. The method of claim 31 , wherein the rotating field vector is obtained by simultaneously applying non-identical AC voltages to different sets of electrodes.

33. An apparatus for selectively destroying or inhibiting the growth of rapidly dividing cells located within a target region of a patient, the apparatus comprising:

an AC voltage source;

a set of at least three insulated electrodes, wherein each of the electrodes has a surface configured for placing against the patient's body; and

a switching mechanism that sequentially applies an output of the AC voltage source between different members of the set of electrodes,

wherein the AC voltage source, the switching mechanism, and the electrodes are configured so that, when the electrodes are placed against the patient's body, an AC electric field is imposed in the target region of the patient, the imposed electric field having frequency characteristics that correspond to a vulnerability of the rapidly dividing cells, wherein the electric field is strong enough to damage, during the late anaphase or telophase stages of cell division, a significant portion of the rapidly dividing cells whose long axis is generally aligned with the lines of force of the electric field, and wherein the electric field leaves non-dividing cells located within the target region substantially unchanged.

34. The apparatus of claim 33 , wherein the surface of each of the electrodes is insulated from the AC voltage source by a thin dielectric coating that has a very high dielectric constant.

35. The apparatus of claim 33 , wherein the frequency of the electric field is between about 50 kHz and about 500 kHz.

36. The apparatus of claim 35 , wherein the strength of the electric field in at least a portion of the target region is between about 0.1 V/cm and about 10 V/cm.

37. The apparatus of claim 33 , wherein the frequency of the electric field is between about 100 kHz and about 300 kHz.

38. The apparatus of claim 37 , wherein the strength of the electric field in at least a portion of the target region is between about 1 V/cm and about 5 V/cm.

39. The apparatus of claim 33 , wherein the orientation of the imposed electric field is gradually and sequentially shifted through a large number of orientations to generate a field vector that rotates with respect to the target region.

40. The apparatus of claim 39 , wherein the rotating field vector is obtained by simultaneously applying non-identical AC voltages to different sets of electrodes.

41. An apparatus for selectively destroying or inhibiting the growth of rapidly dividing cells located within a target region of a patient, the apparatus comprising:

an AC voltage source;

a set of at least three insulated electrodes, wherein each of the electrodes has a surface configured for placing against the patient's body; and

a switching mechanism that sequentially applies an output of the AC voltage source between different members of the set of electrodes,

wherein the AC voltage source, the switching mechanism, and the electrodes are configured so that, when the electrodes are placed against the patient's body, an AC electric field is imposed in the target region of the patient, the imposed electric field having frequency and field strength characteristics that cause the electric field to (a) selectively damage cells that are undergoing cell division and (b) leave cells that are not undergoing cell division substantially unharmed.

42. The apparatus of claim 41 , wherein the surface of each of the electrodes is insulated from the AC voltage source by a thin dielectric coating that has a very high dielectric constant.

43. The apparatus of claim 41 , wherein the frequency of the electric field is between about 50 kHz and about 500 kHz.

44. The apparatus of claim 43 , wherein the strength of the electric field in at least a portion of the target region is between about 0.1 V/cm and about 10 V/cm.

45. The apparatus of claim 41 , wherein the frequency of the electric field is between about 100 kHz and about 300 kHz.

46. The apparatus of claim 45 , wherein the strength of the electric field in at least a portion of the target region is between about 1 V/cm and about 5 V/cm.

47. The apparatus of claim 41 , wherein the orientation of the imposed electric field is gradually and sequentially shifted through a large number of orientations to generate a field vector that rotates with respect to the target region.

48. The apparatus of claim 47 , wherein the rotating field vector is obtained by simultaneously applying non-identical AC voltages to different sets of electrodes.

49. An apparatus for selectively destroying or inhibiting the growth of rapidly dividing cells located within a target region of a patient, the apparatus comprising:

an AC voltage source;

a first pair of insulated electrodes;

a second pair of insulated electrodes; and

a switching mechanism that are operatively connects the first pair of insulated electrodes to the AC voltage source during a first period of time so that a first AC electric field with a first orientation is imposed in the target region of the patient during the first period of time and operatively connects the second pair of insulated electrodes to the AC voltage source during a second period of time so that a second AC electric field with a second orientation is imposed in the target region of the patient during the second period of time, wherein the second orientation is different from the first orientation and the second period of time is subsequent to the first period of time,

wherein each of the electrodes has a surface configured for placing against the patient's body, and wherein the first and second electric fields have frequency and field strength characteristics that cause the first and second electric fields to (a) selectively damage cells that are undergoing cell division and (b) leave cells that are not undergoing cell division substantially unharmed.

50. The apparatus of claim 49 , wherein the surfaces of each of the electrodes is insulated from the AC voltage source by a thin dielectric coating that has a very high dielectric constant.

51. The apparatus of claim 49 , wherein the frequency of the first and second electric fields is between about 50 kHz and about 500 kHz.

52. The apparatus of claim 51 , wherein the strength of the first and second electric fields in at least a portion of the target region is between about 0.1 V/cm and about 10 V/cm.

53. The apparatus of claim 49 , wherein the frequency of the first and second electric fields is between about 100 kHz and about 300 kHz.

54. The apparatus of claim 53 , wherein the strength of the first and second electric fields in at least a port ion of the target region is between about 1 V/cm and about 5 V/cm.

Assignments (15)
PATENT SECURITY AGREEMENT Recorded May 4, 2024
From: NOVOCURE GMBH (SWITZERLAND)
To: BIOPHARMA CREDIT PLC
Reel/Frame 067315/0399 →
RELEASE OF SECURITY INTEREST Recorded Apr 24, 2024
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: NOVOCURE GMBH
Reel/Frame 067211/0839 →
SECURITY INTEREST Recorded Nov 6, 2020
From: NOVOCURE GMBH
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 054344/0510 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 45278 0825 Recorded Aug 25, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 053597/0335 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 50395/0398 Recorded Aug 19, 2020
From: BPCR LIMITED PARTNERSHIP
To: NOVOCURE GMBH
Reel/Frame 053538/0623 →
OMNIBUS CONFIRMATION OF ASSIGNMENT AGREEMENT Recorded May 21, 2020
From: BIOPHARMA CREDIT PLC
To: BPCR LIMITED PARTNERSHIP
Reel/Frame 052741/0173 →
RELEASE OF SECURITY INTEREST FOR PATENT SECURITY AGREEMENT FILED AT REEL/FRAME 045278/0825 Recorded Apr 14, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052391/0549 →
RELEASE OF SECURITY INTEREST Recorded Apr 13, 2020
From: BIOPHARMA CREDIT PLC
To: NOVOCURE LIMITED
Reel/Frame 052383/0705 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 20, 2019
From: NOVOCURE LIMITED
To: NOVOCURE GMBH
Reel/Frame 050110/0098 →
SECURITY INTEREST Recorded May 6, 2019
From: NOVOCURE GMBH
To: BIOPHARMA CREDIT PLC
Reel/Frame 050395/0398 →
RELEASE OF SECURITY INTEREST Recorded Feb 7, 2018
From: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
To: NOVOCURE LIMITED
Reel/Frame 044858/0416 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045278/0825 →
SECURITY INTEREST Recorded Feb 7, 2018
From: NOVOCURE LIMITED
To: BIOPHARMA CREDIT PLC
Reel/Frame 045284/0851 →
SECURITY INTEREST Recorded Feb 2, 2015
From: NOVOCURE LIMITED
To: BIOPHARMA SECURED INVESTMENTS III HOLDINGS CAYMAN LP
Reel/Frame 034866/0402 →
RELEASE OF SECURITY INTEREST Recorded Dec 20, 2013
From: DEUTSCHE BANK TRUST COMPANY AMERICAS
To: NOVOCURE LIMITED
Reel/Frame 031866/0567 →